Edgewise Therapeutics Files 8-K on Financials
Ticker: EWTX · Form: 8-K · Filed: May 8, 2025 · CIK: 1710072
| Field | Detail |
|---|---|
| Company | Edgewise Therapeutics, Inc. (EWTX) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Edgewise Therapeutics dropped an 8-K May 8th detailing financials. Check it.
AI Summary
Edgewise Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 1715 38th St., Boulder, CO 80301.
Why It Matters
This filing provides crucial updates on Edgewise Therapeutics' financial health and operational performance, which are key indicators for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate new risks or significant events disclosed.
Key Players & Entities
- Edgewise Therapeutics, Inc. (company) — Registrant
- May 8, 2025 (date) — Filing date
- 1715 38th St., Boulder, CO 80301 (location) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed with the SEC?
The report was filed on May 8, 2025.
What is the primary business of Edgewise Therapeutics, Inc. according to the filing?
The Standard Industrial Classification code provided is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are Edgewise Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 1715 38th St., Boulder, CO 80301.
What is the Commission File Number for Edgewise Therapeutics, Inc.?
The Commission File Number is 001-40236.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Edgewise Therapeutics, Inc. (EWTX).